Midland Wealth Advisors’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.06M Sell
11,706
-957
-8% -$245K 0.14% 36
2026
Q2
$3.19M Sell
12,663
-248
-2% -$53.4K 0.15% 35
2026
Q1
$2.81M Sell
12,911
-493
-4% -$109K 0.14% 36
2025
Q4
$3.06M Sell
13,404
-1,792
-12% -$408K 0.16% 34
2025
Q3
$3.52M Buy
15,196
+1,009
+7% +$205K 0.19% 34
2025
Q2
$2.63M Sell
14,187
-110
-0.8% -$20.4K 0.15% 32
2025
Q1
$3M Sell
14,297
-1,121
-7% -$218K 0.18% 30
2024
Q4
$2.74M Buy
15,418
+45
+0.3% +$8.27K 0.16% 36
2024
Q3
$3.04M Sell
15,373
-2,407
-14% -$449K 0.18% 31
2024
Q2
$3.05M Buy
17,780
+421
+2% +$69.7K 0.18% 35
2024
Q1
$3.16M Buy
17,359
+596
+4% +$103K 0.19% 29
2023
Q4
$2.6M Buy
+16,763
New +$2.44M 0.18% 31

Other funds holding ABBV

Midland Wealth Advisors's ABBV Position: Q3 2026 in Review

Midland Wealth Advisors reduced its AbbVie (ABBV) stake by 7.6% in Q3 2026, selling an estimated $245K and leaving 11,706 shares worth $3.06M. The position accounts for 0.14% of the portfolio, ranked #36.

Midland Wealth Advisors first reported a position in ABBV in Q4 2023 and has held it in 12 quarters since. The position peaked at $3.52M in Q3 2025. 4,285 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Midland Wealth Advisors held 11,706 shares of AbbVie worth $3.06M as of Q3 2026.
  • Midland Wealth Advisors sold 957 AbbVie shares in Q3 2026, an estimated $245K.
  • AbbVie made up 0.14% of Midland Wealth Advisors's portfolio in Q3 2026, its #36 holding.
  • Midland Wealth Advisors first reported a position in AbbVie in Q4 2023 and has held it in 12 quarters since.
  • Midland Wealth Advisors's AbbVie position peaked at $3.52M in Q3 2025.
  • 4,285 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Midland Wealth Advisors's 13F filing for Q3 2026, filed 26 Oct 2026.